Second Look – Clinical News and Views

Hand and  wrist

  Dupuytren disease—Data from a study published in The Journal of Hand Surgery (online) suggest high satisfaction for patients with Dupuytren disease who are  treated with collagenase clostridium histolyticum (CCH) injection. The research  team conducted a cross-sectional study of 213 patients who had been treated for  Dupuytren disease with CCH. They found that 73 percent of patients were very  satisfied or satisfied, and 21 percent were dissatisfied. Overall, 75 percent  said they would probably or definitely undergo CCH treatment again, and 17 percent  probably or definitely would not. The research team found that satisfaction and  willingness to undergo a second treatment decreased over time, and had a  negative relationship with recurrence.

This content is only available to members of the AAOS.

Please log in using the link at the top right corner of this page to access your exclusive AAOS member content.

Not a member? Become a member!